"Ho hlakile" ho bolela'ng?
Phoofolo ha e jare phetoho ea phetoho. E ke ke ea hlahisa lefu lena mme e ke ke ya e fetisa.
Discover the importance of the DNA test for Autoimmune Lymphoproliferative Syndrome (ALPS) in cats, a genetic disorder affecting the immune system. Early detection through this specialized DNA test helps identify carriers and affected cats, enabling breeders and pet owners to make informed decisions. ALPS can cause abnormal lymphocyte accumulation, leading to severe health issues in cats. By using the ALPS DNA test, you ensure better health management and prevent the spread of this hereditary condition. Trust reliable veterinary genetics labs for accurate and fast results. Protect your feline companion’s health with proactive genetic screening today. Stay informed and keep your cat safe from ALPS with cutting-edge DNA testing.
Autoimmune Lymphoproliferative Syndrome (ALPS) in cats is a rare genetic disorder affecting the immune system. A DNA test can identify mutations linked to ALPS, helping in early diagnosis. This test aids veterinarians in managing the condition and preventing severe immune complications. Early detection through genetic screening improves treatment outcomes. Responsible breeding practices can reduce the incidence of ALPS in feline populations.
Teko ena ea DNA e kenyelelitsoe ho qala ka pakete ea rona Basic - hape ke karolo ea lipakete Basic, Standard, Advanced, Complete.
Sheba Liphutheloana tsa Tlhahlobo ea DNA →Autoimmune Lymphoproliferative Syndrome (ALPS) is a rare genetic disorder that affects the immune system of cats. It is characterized by the abnormal proliferation of lymphocytes, which are a type of white blood cell crucial for immune responses. This condition can lead to various health issues, including persistent lymphadenopathy (swollen lymph nodes), anemia, and an increased susceptibility to infections.
Cats with ALPS may display a range of clinical symptoms, including recurrent fevers, weight loss, lethargy, and skin lesions. The overproduction of lymphocytes can result in hypergammaglobulinemia, which is an elevated level of immunoglobulins in the blood. This can compromise the normal functioning of the immune system, leading to autoimmune disorders where the body mistakenly attacks its own tissues.
ALPS is primarily caused by mutations in specific genes that regulate lymphocyte apoptosis, the process of programmed cell death. In healthy cats, lymphocytes undergo apoptosis after they have completed their immune function, preventing their excessive accumulation. However, in ALPS-affected cats, the dysregulation of this process leads to the survival of excess lymphocytes, contributing to the clinical symptoms observed.
While clinical signs may suggest ALPS, a definitive diagnosis often requires genetic testing. A DNA test can identify mutations associated with the syndrome, allowing veterinarians to confirm the presence of ALPS. Early diagnosis is crucial, as it can guide treatment options and management strategies to improve the quality of life for affected cats.
Management of ALPS in cats typically involves immunosuppressive therapies to reduce lymphocyte proliferation and the associated symptoms. Corticosteroids and other immunosuppressants may be prescribed to help control the immune response. Additionally, supportive care, including proper nutrition and management of secondary infections, is essential in ensuring the well-being of affected cats.
The prognosis for cats diagnosed with ALPS can vary widely depending on the severity of the condition and the response to treatment. Regular veterinary check-ups and monitoring are essential to manage the disease effectively. Owners should be aware of the potential for recurrent infections and other complications, and they should work closely with their veterinarian to establish a comprehensive care plan tailored to their cat’s needs.
Phoofolo ha e jare phetoho ea phetoho. E ke ke ea hlahisa lefu lena mme e ke ke ya e fetisa.
Che. Ka kakaretso phoofolo ena e phetse hantle empa e ka fetisetsa phetoho eo ho eona bana.
E na le likopi tse peli tse fetotsoeng. Matšoao a kliniki a lebelletsoe ho latela lefu lena. Ha ea lokela ho hōlisoa.
Mafu a mang a amahanngoa le thobalano, kahoo polelo ea bona e fapana ho latela thobalano ea phoofolo.
This DNA test detects the mutation associated with Autoimmune Lymphoproliferative Syndrome (ALPS) in order to identify clear, carrier, or at-risk animals.
Teko ea DNA e thusa bahlahisi ho rera ho nyalana ho sireletsehileng le ho fokotsa kotsi ea ho fetisetsa phetoho ho bana.
Mokhoa oa lefa o tlalehiloeng bakeng sa tlhahlobo ena ke Autosomal Recessive.
This test analyses the mutation FASLG c.418dup.
Eseng hakaalo. Tlhaloso e itšetlehile ka mokhoa oa lefa le genotype e hlahisoang.
Aberdein Danielle, Munday John S, Gandolfi Barbara, Dittmer Keren E, Malik Richard, Garrick Dorian J, Lyons Leslie A. A FAS-ligand variant associated with autoimmune lymphoproliferative syndrome in cats. Mamm Genome. 2017 Feb;28(1-2):47-55. doi: 10.1007/s00335-016-9668-1. Epub 2016 Oct 21.
Lekunutu la hao, khetho ea hao
Re sebelisa li-cookies tsa bohlokoa ho tsamaisa webosaete. Li-cookie tsa boikhethelo (joalo ka bafani ba litaba tse kentsoeng) li koetsoe ka mokhoa oa kamehla, 'me li ka lumelloa feela ha u lumela. U ka fetola khetho ea hau ka nako efe kapa efe u sebelisa konopo ea "Cookies".
E hlokahala bakeng sa likarolo tsa mantlha le polokeho. E lumelletsoe kamehla.
E ntlafatsa likarolo tse kang ho boloka lintho tseo u li ratang kapa tseo e seng tsa papatso.
E re thusa ho utloisisa tšebeliso ea sebaka sa marang-rang. E emisitsoe ka ho sa feleng.
Papatso/ho sala morao libakeng tsohle (lifitio/limmapa tse ling tse kentsoeng). E emisitsoe ka ho sa feleng.